Search results for: 'Radar AND MDR'
- Did you mean
- radar ad mdr
- radar and mbr
- Related search terms
- Radar in the Global Smart Water Meter Market report
- radar in the global smart water me1e market report
- radar in the global smart water me0e market report
- radar in the global smart water mine market report
- radar in the global smart water more market report
-
24 Oct 2025  |  North America  |  Frost Radar
Frost Radar™: Healthcare Payer-Provider Collaboration Solutions in North America, 2025
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
This Frost Radar™ analysis investigates the healthcare platforms and tools that enhance communication and collaboration between care providers and payers for services, as well as the interfaces that connect payers and providers directly. The payer is often a private insurer, but could also be a patient or a government entity. As the industry transi...
$4,950.00 -
17 Aug 2022  |  North America  |  Frost Radar
Frost Radar™: Global Clinical Trial IT Solutions Market, 2022
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
COVID-19 has accelerated the need for a faster, more accessible clinical trial process. During the height of the pandemic, in-person follow-ups for ongoing trials were replaced with hand-held devices that essentially built an ecosystem for home health care support services that can be easily leveraged to avoid or reduce participant dropout rates. ...
$4,950.00
Special Price $3,712.50 save 25 %
-
23 Sep 2019  |  North America  |  Frost Radar
Frost Radar in the Immunoassay and Clinical Chemistry Market
A Measurement System to Spark Companies 2 Action (C2A)—Innovation That Fuels New Deal Flow and Growth Pipelines
The immunoassay and clinical chemistry market is the highest share contributor for the total in vitro diagnostics (IVD) market. Globally valued at $28.7 billion in 2019, this market segment contributes 37.6% of the total IVD market of $76.3 billion. Within the high-medium to low analyzer segment, there are over 40 companies globally. Of these, 14 c...
$4,950.00
Special Price $3,712.50 save 25 %
-
16 Nov 2022  |  North America  |  Frost Radar
Frost Radar™: Cell and Gene Therapy Contract Development and Manufacturing Organizations, 2022
A Benchmarking System to Spark Companies to Action-Innovation that Fuels New Deal Flow and Growth Pipelines
As cell and gene therapy (CGT) moves from ultra-rare indications to more common indications, manufacturing capabilities will have to expand to support the commercial requirements of these diseases. Contract research organizations (CROs) can play a critical role in long-term genetic analysis and monitor safety and efficacy up to 15 years after treat...
$4,950.00
Special Price $3,712.50 save 25 %
-
08 Nov 2023  |  North America  |  Frost Radar
Frost Radar™: Point-of-Care Ultrasound (Portable and Ultraportable), 2023
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
Portable and ultraportable point-of-care ultrasound (POCUS) systems have gained prominence in recent years due to their versatility and ease of use. These devices allow clinicians to acquire high-resolution images in real time and enable fast and well-informed clinical decisions, particularly in care settings where mobility and user-friendliness ar...
$4,950.00
Special Price $3,712.50 save 25 %
-
29 Jun 2021  |  North America  |  Frost Radar
Frost Radar™: Digital Operating Rooms, 2020
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
Hospitals are under extreme pressure to reduce costs and become more profitable. Operating rooms (ORs) drive approximately 60% of revenue in the average hospital. The most critical issues entail finding new methods to reduce human error and improve the efficiency and quality of surgical care. Technology is now available to help hospitals reduce sur...
$4,950.00
Special Price $3,712.50 save 25 %
-
19 Aug 2022  |  North America  |  Frost Radar
Frost Radar™: Healthcare Data Analytics, 2022
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
Healthcare organizations must be able to manage, analyze, and interpret data in order to identify strategic, tactical, and operational insights for decision making. This allows providers and payers to provide the best ways of delivering high-quality care. There has been a slow but steady change in the healthcare industry at the very core of its bus...
$4,950.00
Special Price $3,712.50 save 25 %
-
23 Dec 2020  |  North America  |  Frost Radar
Frost Radar™: US Healthcare Cybersecurity Market, 2020
A Benchmarking System to Spark Companies to Action—Innovation That Fuels New Deal Flow and Growth Pipelines
The US healthcare cybersecurity market is poised for aggressive growth after the COVID-19 pandemic ends. The impending challenges related to the top 5 cyber threats (phishing attacks, credential harvesting, ransomware, social engineering attacks, and information theft or loss) will drive a higher spend on progressive cybersecurity solutions across...
$4,950.00
Special Price $3,712.50 save 25 %
-
16 Aug 2022  |  North America  |  Market Research
Global Cell and Gene Therapy (CGT) Growth Opportunities
The Shift to Prevalent Diseases and Allogeneic Cell Therapies Creates New Growth Opportunities in the CGT Value Chain
This Frost & Sullivan study examines the global cell and gene therapy (CGT) market. It highlights revenue forecasts and key growth opportunities for CGT market participants based on the evolution of their business models and strategic approaches as well as investments and regulations. The study segments the market by product (cell therapy, gene-mod...
$4,950.00
Special Price $3,712.50 save 25 %
-
25 Apr 2022  |  North America  |  Frost Radar
Frost Radar™: Artificial Intelligence-enabled Drug Discovery, 2022
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
Pharmaceutical drug discovery and development has been suffering from declining success rates with new molecules primarily because of poor external validity of preclinical models and lack of efficacy of the molecule in terms of the intended disease indication. Drug success rates continue to be in the range of only 1 in 10 that enters clinical phase...
$4,950.00
Special Price $3,712.50 save 25 %